Richard Chin insider trades: Kindred Biosciences (KIN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 2, 2021 | KIN | ↓ Sell | 40,000 | $9.21 | $368K | Direct | Aug 4, 2021 (2d) |
| Jul 2, 2021 | KIN | ↓ Sell | 40,000 | $9.18 | $367K | Direct | Jul 7, 2021 (5d) |
| Jun 16, 2021 | KIN | ↓ Sell | 40,000 | $9.18 | $367K | Direct | Jun 17, 2021 (1d) |
| Jan 2, 2019 | KIN | ↓ Sell | 40,000 | $10.57 | $423K | Direct | Jan 4, 2019 (2d) |
| Dec 3, 2018 | KIN | ↓ Sell | 40,000 | $13.28 | $531K | Direct | Dec 4, 2018 (1d) |
| Nov 1, 2018 | KIN | ↓ Sell | 40,000 | $14.68 | $587K | Direct | Nov 2, 2018 (1d) |
| Oct 1, 2018 | KIN | ↓ Sell | 40,000 | $13.28 | $531K | Direct | Oct 3, 2018 (2d) |
| Sep 5, 2018 | KIN | ↓ Sell | 40,000 | $14.79 | $591K | Direct | Sep 6, 2018 (1d) |
| Aug 1, 2018 | KIN | ↓ Sell | 40,000 | $13.51 | $540K | Direct | Aug 3, 2018 (2d) |
| Jul 2, 2018 | KIN | ↓ Sell | 40,000 | $10.28 | $411K | Direct | Jul 3, 2018 (1d) |
| Jun 1, 2018 | KIN | ↓ Sell | 52,610 | $10.10 | $531K | Direct | Jun 1, 2018 (0d) |
| May 25, 2018 | KIN | ↓ Sell | 3,060 | $10.00 | $31K | Direct | May 29, 2018 (4d) |
| May 18, 2018 | KIN | ↓ Sell | 2,400 | $10.00 | $24K | Direct | May 18, 2018 (0d) |
| May 9, 2018 | KIN | ↓ Sell | 1,930 | $10.01 | $19K | Direct | May 9, 2018 (0d) |
| May 1, 2018 | KIN | ↓ Sell | 20,000 | $9.05 | $181K | Direct | May 2, 2018 (1d) |
| Apr 2, 2018 | KIN | ↓ Sell | 20,000 | $8.39 | $168K | Direct | Apr 4, 2018 (2d) |
| Jul 3, 2017 | KIN | ↓ Sell10b5-1 | 13,000 | $8.26 | $107K | Direct | Jul 6, 2017 (3d) |
| Jun 22, 2017 | KIN | ↓ Sell | 13,000 | $7.75 | $101K | Direct | Jun 26, 2017 (4d) |
| Feb 12, 2014 | GALE | ↓ Sell | 187,500 | $4.33 | $812K | Direct | Feb 13, 2014 (1d) |
| Jan 30, 2014 | GALE | ↓ Sell | 75,000 | $5.58 | $419K | Direct | Feb 3, 2014 (4d) |
| Sep 15, 2006 | OXGN | ↑ Buy | 45,464 | $4.09 | $186K | Direct | Sep 18, 2006 (3d) |
| Aug 1, 2006 | OXGN | ↑ Buy | 20,000 | $3.30 | $66K | Direct | Aug 3, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Richard Chin's insider trades
Richard Chin is Chief Executive Officer at Kindred Biosciences (KIN). Since Aug 1, 2006, Richard has reported 2 open-market purchases worth $252K and 20 sales worth $7.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (2% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (31 filings), option exercises (13 filings), shares withheld for taxes (7 filings), gifts (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KIN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.